Metabolism of topical retinaldehyde

Dermatology

Volumn 199, Issue SUPPL. 1, 1999, Pages 13-17

  Sorg, O ^a   Didierjean, L ^a   Saurat, Jean Hilarie ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Epidermis; Metabolism; Retinaldehyde; Retinoids

Indexed keywords

RETINAL; RETINOIC ACID; RETINOL ESTER;

ANIMAL EXPERIMENT; CELL CULTURE; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG METABOLISM; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET IRRADIATION;

ADMINISTRATION, TOPICAL; ANIMALS; BIOLOGICAL AVAILABILITY; CELL FRACTIONATION; CELLS, CULTURED; CYTOSOL; HUMANS; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED HRS; RETINALDEHYDE; RETINOIDS; SKIN;

EID: 0032774142     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051372     Document Type: Conference Paper

References (11)

1. Bhawan J, Olsen E, Lufrano L, Thorne EG, Schwab B, Gilchrest BA: Histologic evaluation of the long-term effects of tretinoin on photodamaged skin. J Dermatol Sci 1996;11:177-182.
2. Thorne EG, Lufrano L, Boateng F, Sampson AR: Effect of tretinoin emollient cream on photodamaged skin: Relationship between clinical improvement and skin irritation. Br J Dermatol 1996;135:655-656.
3. Saurat JH, Didierjean L, Masgrau E, Piletta PA, Jaconi S, Chatellard-Gruaz D, Gumowski D, Masouyé I, Salomon I, Siegenthaler G: Topical retinaldehyde on human skin: Biological effects and tolerance. J Invest Dermatol 1994; 103:770-774.
4. Siegenthaler G, Gumowski-Sunek D, Saurat JH: Metabolism of natural retinoids in psoriatic epidermis. J Invest Dermatol 1990;95:47S-48S.
5. Châtellard-Gruaz D, Randolph RK, Hagens G, Saurat JH, Siegenthaler G: Differentiation of human epidermal keratinocytes is accompanied by increased expression of CRABP-II and increased cellular concentration of retinoic acids: Retention of newly synthesized retinoic acids by CRABP-II. J Lipid Res 1998;39: 1421-1429.
6. Didierjean L, Sass JO, Carraux P, Grand D, Sorg O, Plum C, Nau H, Saurat JH: Topical 9-cis-retinaldehyde for delivery of 9-cis-retinoic acid in mouse skin. Exp Dermatol, in press.
7. Didierjean L, Carraux P, Grand D, Sass JO, Nau H, Saurat JH: Topical retinaldehyde increases skin content of retinoic acid and exerts biological activity in mouse skin. J Invest Dermatol 1996;107:714-719.
8. Crettaz M, Baron A, Siegenthaler G, Hunziker W: Ligand specificities of recombinant retinoic acid receptors RARa and RARb. Biochem J 1990;272:391-397.
9. Repa JJ, Hanson KK, Clagett-Dame M: All-trans-retinol is a ligand for the retinoic acid receptors. Proc Natl Acad Sci USA 1993;90: 7293-7297.
10. Lombardo A, Costa E, Chao WR, Toll L, Hobbs PD, Jong L, Lee MO, Pfahl M, Ely KR, Dawson MI: Recombinant human retinoic acid receptor beta: Binding of synthetic retinoids and transcriptional activation. J Biol Chem 1994;269: 7297-7303.
11. Duell EA, Åström A, Griffiths CEM, Chambon P, Voorhees JJ: Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro. J Clin Invest 1992;90:1269-1274.